Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124913933 | 12491393 | 3 | F | 2016 | 20160804 | 20160623 | 20160809 | EXP | US-009507513-1606USA009517 | MERCK | 91.64 | YR | M | Y | 0.00000 | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124913933 | 12491393 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | EVERY WEEK | U | 12675 | TABLET | /wk | ||||||||
| 124913933 | 12491393 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 16 MG, QW | U | 12675 | 16 | MG | TABLET | /wk | ||||||
| 124913933 | 12491393 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 25 MG, QD | 330 | MG | U | 0 | 25 | MG | CAPSULE | QD | |||
| 124913933 | 12491393 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 15 MG, QD | 330 | MG | U | 0 | 15 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124913933 | 12491393 | 1 | Product used for unknown indication |
| 124913933 | 12491393 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124913933 | 12491393 | DE |
| 124913933 | 12491393 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124913933 | 12491393 | Decreased appetite | |
| 124913933 | 12491393 | Fatigue | |
| 124913933 | 12491393 | Haematocrit decreased | |
| 124913933 | 12491393 | Haemoglobin decreased | |
| 124913933 | 12491393 | Muscular weakness | |
| 124913933 | 12491393 | Peripheral swelling | |
| 124913933 | 12491393 | Plasma cell myeloma | |
| 124913933 | 12491393 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124913933 | 12491393 | 1 | 2016 | 0 | ||
| 124913933 | 12491393 | 2 | 2016 | 0 | ||
| 124913933 | 12491393 | 3 | 201601 | 0 | ||
| 124913933 | 12491393 | 4 | 20160204 | 20160225 | 0 |